Patents

Name: Cross-linked Star-shaped self-assembled polyglutamates and its use as carriers in
biomedical applications.

Inventors/authors/obtainers: Vicent J. Nebot; Aroa Duro-Castaño; Maria J. Vicent.
Holding institution: Centro de Investigación Príncipe Felipe.
Application number: European patent EP15382422.2.
Priority country: Spain
Date: 08/08/2015.

Name: Novel Polymer-drug conjugates for the treatment of amyloidosis

Inventors/authors/obtainers: María J. Vicent Docón; Inmaculada Conejos Sánchez
Holding institution: Centro de Investigación Príncipe Felipe
Application number: European Patent EP13382184
Priority country: Spain
Date: 20/05/2013

Name: Sintesis controlada de poliglutamatos con baja polidispersidad y arquitecturas versátiles

Description of qualities: Generación Spin Off Polypeptide Therapeutic Solutions SL
Type of industrial property: Patent of invention
Inventors/authors/obtainers: María J. Vicent; Matthias Barz; Aroa Duro; Inma Conejos; Fabiana Canal; Richard England
Holding institution: Centro de Investigación Príncipe Felipe
Application number: PCT/ES2012/070740
Priority country: Spain
Date: 24/10/2011
Conferral date: 21/10/2012
Spanish patent: Yes
PCT patent: Yes
Licences: Yes
Commercial use, exclusive: Yes
Creating an innovative enterprise: Yes Results: Success

Name: Novel conjugates of polymers having a therapeutically active agent and an angiogenesis targeting moiety attached thereto and uses thereof in the treatment of angiogenesis related diseases

Description of qualities: En proceso de licencia a farmacéutica
Type of industrial property: Patent of invention
Inventors/authors/obtainers: Ronit Satchi-Fainaro; María Jesús Vicent Docón
Holding institution: Centro de Investigación Príncipe Felipe and Tel Aviv University
Application number: WO/2009/141826
Priority country: United States of America
Date: 22/05/2008
Conferral date: 26/11/2009
Patent number: WO/2009/141826
EU patent: Yes
International non-EU patent: Yes PCT patent: Yes
Extended to: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. African Regional Intellectual Property Org. (ARIPO) (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW) Eurasian Patent Organization (EAPO) (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM) European Patent Office (EPO) (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR) African Intellectual Property Organization (OAPI) (BF, BJ, CF,CG , CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).

Name: Novel Nanoconjugates for the treatment of sepsis.

Inventors/authors/obtainers: (in order of authorship): María J. Vicent; Enrique Pérez-Payá; Angel Messeguer; Laura Cascales
Holding institution: Centro de Investigación Príncipe Felipe y CSIC
Application number: PCT/2010/30218
Priority country: Spain
Date: 28/05/2009

Name: Polymer conjugate compounds for the inhibition of apoptosis.

Type of industrial property: Patent of invention
Inventors/authors/obtainers: E. Pérez-Payá; À. Messeguer; M.J. Vicent; G. Malet; M. Orzáez; L. Mondragón; G. Sanclimens; A. Moure
Holding institution: Centro de Investigación Príncipe Felipe y CSIC
Application number: WO/2008/141762
Priority country: Spain
Date: 21/05/2007
Conferral date: 27/11/2008
PCT patent: Yes
Licences: Yes
Companies: Salvat Labs.
Commercial use, exclusive: Yes
Extended to: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. African Regional Intellectual Property Org. (ARIPO) (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW) Eurasian Patent Organization (EAPO) (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM) European
Patent Office (EPO) (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR) African Intellectual Property Organization (OAPI) (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).

Name: Composición farmacéutica para inhibir la apoptosis

Type of industrial property: Patent of invention
Inventors/authors/obtainers: E. Pérez-Payá; À. Messeguer; M.J. Vicent; G. Malet; M. Orzáez; L.Mondragón; G. Sanclimens; A. Moure
Holding institution: Centro de Investigación Príncipe Felipe y CSIC
Application number: WO/2007/060524
Priority country: Spain
Date: 01/06/2005
Conferral date: 22/11/2006
Spanish patent: Yes EU patent: Yes
International non-EU patent: Yes PCT patent: Yes
Licences: Yes
Companies: Laboratorios Salvat, S.A.
Commercial use, exclusive: Yes
Extended to: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM,GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA,MD, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. African Regional Intellectual Property Org. (ARIPO) (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW) Eurasian Patent Organization (EAPO) (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM) European Patent Office (EPO) (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR) African Intellectual Property Organization (OAPI) (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).